NCT04748159

Effects of Prone Positioning on Vital Parameters in Infants With Acute Bronchiolitis

Completed NA Last updated 26 March 2024

What this trial tests

NA trial testing Prone position/ Abdominal position in Respiratory Syncytial Virus (RSV) in 27 participants. Completed in 31 March 2020.

Timeline

3 January 2020

Primary endpoint
23 March 2020

31 March 2020

Quick facts

Lead sponsor	Luzerner Kantonsspital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	27
Start date	3 January 2020
Primary completion	23 March 2020
Estimated completion	31 March 2020
Sites	1 location across Switzerland

Drugs / interventions tested

• Prone position/ Abdominal position

Conditions studied

• Respiratory Syncytial Virus (RSV) — all drugs for Respiratory Syncytial Virus (RSV) →
• Acute Bronchiolitis — all drugs for Acute Bronchiolitis →
• Infant, Newborn, Disease — all drugs for Infant, Newborn, Disease →
• Infant, Premature, Diseases — all drugs for Infant, Premature, Diseases →

Sponsor

Luzerner Kantonsspital — full company profile →

Who can join

Adults 0 Months to 12 Months, any sex, with Respiratory Syncytial Virus (RSV) or Acute Bronchiolitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This intervention study is designed to evaluate short-term effects (within one hour) of prone position on vital signs in infants under 12 months of age with acute RSV bronchiolitis. The primary objective is to investigate whether respiratory rate changes in prone position. Secondary endpoints are changes in oxygen saturation (SpO2), transcutaneous carbon dioxide partial pressure (pCO2), heart rate, and respiratory symptoms assessed by the Modified Tal Score (MTS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.